In pancreatic cancer, Hepatocyte Nuclear Factor 1-alpha (HNF1α) has been shown to enhance intron 1 enhancer activity, leading to FGFR4 overexpression and promoting tumor aggressiveness91,.94 Here, HNF1A is linked to neoplasm.